Literature DB >> 11566902

Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.

Y Ozawa1, K Hayashi, T Nagahama, K Fujiwara, T Saruta.   

Abstract

Although calcium antagonists exert preferential vasodilation of renal afferent arterioles, we have recently demonstrated that nilvadipine and efonidipine, possessing both L-type and T-type calcium channel blocking action, reverse the angiotensin (Ang) II-induced afferent and efferent arteriolar constriction. In the present study, we investigated the role of T-type calcium channels in mediating the Ang II-induced efferent arteriolar tone using the selective T-type calcium channel blocker mibefradil. Isolated perfused hydronephrotic rat kidneys were used for direct visualization of renal microcirculation. Administration of Ang II (0.3 nmol/L) caused marked constriction of afferent (from 13.5+/-0.6 to 9.2+/-0.6 microm, P<0.01, n=6) and efferent (from 11.5+/-1.0 to 7.4+/-0.7 microm, P<0.01, n=5) arterioles. Mibefradil (1 micromol/L) dilated both vessels, with 82+/-11% and 72+/-7% reversal of afferent and efferent arterioles, respectively. Similarly, nickel chloride (100 micromol/L) caused dilation of both arterioles, similar in magnitude in afferent (68+/-10%, n=7) and efferent (80+/-7%, n=7) arterioles. To eliminate the possibility that the mibefradil-induced dilation was mediated by L-type channel blockade, mibefradil was administered in the presence of nifedipine (1 micromol/L). Thus, nifedipine caused modest efferent arteriolar dilation (30+/-6% reversal, n=9), and subsequent addition of mibefradil elicited further dilation of this vessel (80+/-4%, P<0.01 versus nifedipine). Furthermore, mibefradil reversed the Ang II-induced efferent arteriolar constriction even in the presence of nifedipine and phentolamine. These findings demonstrate that T-type calcium antagonists markedly dilate the Ang II-induced efferent arteriolar constriction, but the action is not mediated by inhibition of catecholamine release. This potent activity would contribute to the efferent arteriolar response to nilvadipine and efonidipine and may offer benefit in light of glomerular hemodynamics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566902     DOI: 10.1161/01.hyp.38.3.343

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

1.  T-channel-like pharmacological properties of high voltage-activated, nifedipine-insensitive Ca2+ currents in the rat terminal mesenteric artery.

Authors:  Hiromitsu Morita; Juan Shi; Yushi Ito; Ryuji Inoue
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

Review 2.  Low-voltage-activated ("T-Type") calcium channels in review.

Authors:  Anne Marie R Yunker; Maureen W McEnery
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

3.  Voltage-gated divalent currents in descending vasa recta pericytes.

Authors:  Zhong Zhang; Hai Lin; Chunhua Cao; Sandeep Khurana; Thomas L Pallone
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-14

4.  No apparent role for T-type Ca²⁺ channels in renal autoregulation.

Authors:  Rasmus Hassing Frandsen; Max Salomonsson; Pernille B L Hansen; Lars J Jensen; Thomas Hartig Braunstein; Niels-Henrik Holstein-Rathlou; Charlotte Mehlin Sorensen
Journal:  Pflugers Arch       Date:  2015-12-14       Impact factor: 3.657

Review 5.  Vascular effects of calcium channel antagonists: new evidence.

Authors:  Sylvain Richard
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Hyperoxaluria-induced tubular ischemia: the effects of verapamil on the antioxidant capacity of the affected kidneys.

Authors:  Kemal Sarica; Alper Kafkasli; Fehmi Narter; Oguz Ozturk; Ozgur Yazici; Bilal Hamarat; Cahit Sahin; Bilal Eryildirim
Journal:  Urolithiasis       Date:  2016-06-09       Impact factor: 3.436

Review 7.  Calcium-permeable ion channels in the kidney.

Authors:  Yiming Zhou; Anna Greka
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-30

Review 8.  Dihydropyridine calcium channel blockers and renal disease.

Authors:  Nicolás R Robles; Francesco Fici; Guido Grassi
Journal:  Hypertens Res       Date:  2016-07-14       Impact factor: 3.872

9.  Ca(2+) channel blocker benidipine promotes coronary angiogenesis and reduces both left-ventricular diastolic stiffness and mortality in hypertensive rats.

Authors:  Takao Nishizawa; Xian Wu Cheng; Zhehu Jin; Koji Obata; Kohzo Nagata; Akihiro Hirashiki; Takeshi Sasaki; Akiko Noda; Kyosuke Takeshita; Hideo Izawa; Guo-Ping Shi; Masafumi Kuzuya; Kenji Okumura; Toyoaki Murohara
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

10.  Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease.

Authors:  Kiyotsugu Omae; Tetsuya Ogawa; Kosaku Nitta
Journal:  Heart Vessels       Date:  2009-07-22       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.